AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

bioAffinity Technologies, Inc. Director's Dealing 2025

Sep 25, 2025

35439_dirs_2025-09-25_ca4fc04c-7e77-40f3-be72-e50f7c8be9e2.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2025-08-12

Reporting Person: Rios Roberto (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	833	Direct